Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Radioiodine studies with 1231].

W Schaub

    Nuklearmedizin. Nuclear Medicine
    |December 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Iodine-123 (123I) offers a lower radiation dose and superior thyroid scan quality compared to Iodine-131 (131I). This study establishes optimal protocols for 123I tracer studies, yielding reliable results for thyroid imaging.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Diagnosis--therapy and documentation].

    Zeitschrift fur Orthopadie und ihre Grenzgebiete·1992
    Same author

    [The reliability and sources of error in basic clinical documentation--a critical report of experiences].

    Zeitschrift fur Orthopadie und ihre Grenzgebiete·1989
    Same author

    [Clinical value of gastrointestinal bleeding scintigraphy in vivo using 99mTc-labeled erythrocytes].

    Schweizerische medizinische Wochenschrift·1986
    Same author

    [Radiological and scintigraphic evaluation of hip prostheses (author's transl)].

    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·1979
    Same author

    [Radio-isotope investigations in bone and joint disease (author's transl)].

    Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie·1977
    Same author

    [Experiences with Valium in minor surgery].

    Therapie der Gegenwart·1971

    Area of Science:

    • Nuclear medicine
    • Radiopharmacology
    • Medical imaging

    Context:

    • Iodine-131 (131I) has been the standard for thyroid imaging, but its use results in significant radiation exposure.
    • Technetium-99m pertechnetate offers a lower radiation dose but has limitations in reflecting iodine uptake mechanisms, leading to scan discrepancies.
    • Iodine-123 (123I), a cyclotron-produced radioisotope, presents an alternative with a shorter half-life and no beta emission, potentially reducing radiation dose.

    Purpose:

    • To evaluate Iodine-123 (123I) as a superior radiotracer for thyroid imaging compared to Iodine-131 (131I) and 99mTc-pertechnetate.
    • To establish optimal protocols for thyroid uptake and scanning using 123I, considering its shorter half-life.
    • To compare the radiation dosimetry and image quality of 123I with existing agents.

    Related Experiment Videos

    Summary:

    • The study details optimal protocols for 123I thyroid imaging, including 6-hour and 24-hour uptake measurements, 24-hour blood sampling for 123I-iodo-iodo-phenyl-isopropyl-acetanilido (123I-PBJ), and 6-hour scans.
    • Thyroid uptake values and 123I-PBJ results show similarity to 131I, while scans demonstrate improved speed and quality.
    • Recommended doses are 100 microcuries (μCi) for scanning and 300 μCi for complete tracer studies, resulting in significantly lower radiation doses (approx. 1.5 rads thyroid, 3 mrads total body) compared to 131I.

    Impact:

    • 123I provides a safer alternative for thyroid imaging, significantly reducing patient radiation exposure.
    • Enhanced scan quality and speed with 123I improve diagnostic accuracy and patient throughput.
    • The established protocols facilitate the wider adoption of 123I for comprehensive thyroid diagnostics.